Evidence map›Paper›PMID 33653385›Full record

ArticleTrials2021

Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial.

Anca Vasiliu, Sabrina Eymard-Duvernay, Boris Tchounga, Daniel Atwine, Elisabete de Carvalho, Sayouba Ouedraogo, Michael Kakinda, Patrice Tchendjou, Stavia Turyahabwe, Albert Kuate Kuate and 6 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03832023 (Community Intervention for Tuberculosis Active Contact Tracing and Preventive Therapy - a Cluster Randomized Study), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03832023 nacompletednot on this map

Community Intervention for Tuberculosis Active Contact Tracing and Preventive Therapy - a Cluster Randomized Study (CONTACT)

TypeinterventionalSponsorElizabeth Glaser Pediatric AIDS FoundationRan2019 to 2022Enrolled1,400ConditionsTuberculosisArmsScreening and initiating preventive therapy in communities
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anca VasiliuFrench National Research Institute for Sustainable Development (IRD UMI 233 TransVIHMI- UM-INSERM U1175), Montpellier, France.
Sabrina Eymard-DuvernayFrench National Research Institute for Sustainable Development (IRD UMI 233 TransVIHMI- UM-INSERM U1175), Montpellier, France.
Boris TchoungaElizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Daniel AtwineEpicentre Research Center, Mbarara, Uganda.
Elisabete de CarvalhoFrench National Research Institute for Sustainable Development (IRD UMI 233 TransVIHMI- UM-INSERM U1175), Montpellier, France.
Sayouba OuedraogoFrench National Research Institute for Sustainable Development (IRD UMI 233 TransVIHMI- UM-INSERM U1175), Montpellier, France.
Michael KakindaElizabeth Glaser Pediatric AIDS Foundation, Mbarara, Uganda.
Patrice TchendjouElizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Stavia TuryahabweNational Tuberculosis and Leprosy Program, Kampala, Uganda.
Albert Kuate KuateNational Tuberculosis Program, Yaoundé, Cameroon.
Georges TiendrebeogoFrench National Research Institute for Sustainable Development (IRD UMI 233 TransVIHMI- UM-INSERM U1175), Montpellier, France.
Peter J DoddSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
Stephen M GrahamCentre for International Child Health, University of Melbourne and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia.
Jennifer CohnElizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Martina CasenghiElizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Maryline BonnetFrench National Research Institute for Sustainable Development (IRD UMI 233 TransVIHMI- UM-INSERM U1175), Montpellier, France. maryline.bonnet@ird.fr.ORCID http://orcid.org/0000-0002-1071-7393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are major gaps in the management of pediatric tuberculosis (TB) contact investigation for rapid identification of active tuberculosis and initiation of preventive therapy. This study aims to evaluate the impact of a community-based intervention as compared to facility-based model for the management of children in contact with bacteriologically confirmed pulmonary TB adults in low-resource high-burden settings. METHODS/

designThis multicenter parallel open-label cluster randomized controlled trial is composed of three phases: I, baseline phase in which retrospective data are collected, quality of data recording in facility registers is checked, and expected acceptability and feasibility of the intervention is assessed; II, intervention phase with enrolment of index cases and contact cases in either facility- or community-based models; and III, explanatory phase including endpoint data analysis, cost-effectiveness analysis, and post-intervention acceptability assessment by healthcare providers and beneficiaries. The study uses both quantitative and qualitative analysis methods. The community-based intervention includes identification and screening of all household contacts, referral of contacts with TB-suggestive symptoms to the facility for investigation, and household initiation of preventive therapy with follow-up of eligible child contacts by community healthcare workers, i.e., all young (< 5 years) child contacts or older (5-14 years) child contacts living with HIV, and with no evidence of TB disease. Twenty clusters representing TB diagnostic and treatment facilities with their catchment areas are randomized in a 1:1 ratio to either the community-based intervention arm or the facility-based standard of care arm in Cameroon and Uganda. Randomization was stratified by country and constrained on the number of index cases per cluster. The primary endpoint is the proportion of eligible child contacts who initiate and complete the preventive therapy. The sample size is of 1500 child contacts to identify a 10% difference between the arms with the assumption that 60% of children will complete the preventive therapy in the standard of care arm. DISCUSSION: This study will provide evidence of the impact of a community-based intervention on household child contact screening and management of TB preventive therapy in order to improve care and prevention of childhood TB in low-resource high-burden settings.

trial registrationClinicalTrials.gov NCT03832023 . Registered on 6 February 2019.

Indexed as

TuberculosisTuberculosis, PulmonaryChildContact TracingHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicRetrospective StudiesUgandaCluster randomized controlled trialCommunity interventionContact tracingPediatric tuberculosisPreventive therapyTuberculosis symptom screening

Identifiers

PMID33653385
PMCPMC7927252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.